Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding Salt Lake City, UT – October 18, 2023 – DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced a basic science Cooperative Research and […]
Company Ranks Top 2 in Healthcare Equipment and Services Industry
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions
After the release of the first IVDR certificate at the beginning of the year ELITech Group continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories.
CLP Magazine recently interviewed Kristen Smith, senior medical science liaison at bioMérieux
Once-daily, steroid-free roflumilast foam 0.3% demonstrated significant improvements in both scalp and body psoriasis
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award
New multipurpose microcatheter length complements Merit’s radial-first legacy
GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
Funding to Support Research and Expanded Access of Investigational Drug in ALS SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological […]
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children’s Hospital […]
New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in […]
SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]
Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies
Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.
rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools
The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.
EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION PLATFORM
Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients
REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clostridioides difficile infection in 2024.
Nearly three out of four women falsely believe a pap smear will reveal ovarian cancer presence
Myriad Genetics announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune Best Workplaces in Health Care™ List.
Ultradent Products is being recognized for the third consecutive year as a Fortune Magazine Top Large Workplace in Manufacturing and Production.
By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow Read more about Clement Chow’s research […]
19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical worsening events Over 475 years of CNM-Au8 treatment exposure without any identified safety signals SALT LAKE CITY, Aug. 29, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) through its wholly owned subsidiary Clene Nanomedicine Inc., today announced […]
